• 1542 Citations
  • 14 h-Index
20092017
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesco Galimi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Colorectal Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Oncogenes Medicine & Life Sciences
1-Phosphatidylinositol 4-Kinase Medicine & Life Sciences
Cells Chemical Compounds
Growth Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2017

  • 1542 Citations
  • 14 h-Index
  • 15 Article
37 Citations (Scopus)

Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer

Isella, C., Brundu, F., Bellomo, S. E., Galimi, F., Zanella, E., Porporato, R., Petti, C., Fiori, A., Orzan, F., Senetta, R., Boccaccio, C., Ficarra, E., Marchionni, L., Trusolino, L., Medico, E. & Bertotti, A., May 31 2017, In : Nature Communications. 8, 15107.

Research output: Contribution to journalArticle

Heterografts
Colorectal Neoplasms
cancer
Cells
cells
94 Citations (Scopus)

HER2 activating mutations are targets for colorectal cancer treatment

Kavuri, S. M., Jain, N., Galimi, F., Cottino, F., Leto, S. M., Migliardi, G., Searleman, A. C., Shen, W., Monsey, J., Trusolino, L., Jacobs, S. A., Bertotti, A. & Bose, R., Aug 1 2015, In : Cancer Discovery. 5, 8, p. 832-841 10 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Mutation
Therapeutics
Protein-Tyrosine Kinases
erbB-2 Genes
52 Citations (Scopus)

IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies

Zanella, E. R., Galimi, F., Sassi, F., Migliardi, G., Cottino, F., Leto, S. M., Lupo, B., Erriquez, J., Isella, C., Comoglio, P. M., Medico, E., Tejpar, S., Budinská, E., Trusolino, L. & Bertotti, A., Jan 28 2015, In : Science Translational Medicine. 7, 272, 272ra12.

Research output: Contribution to journalArticle

Somatomedins
Epidermal Growth Factor Receptor
Colorectal Neoplasms
Therapeutics
Tumor Biomarkers
136 Citations (Scopus)

Intrinsic resistance to MEK inhibition in kras mutant lung and colon cancer through transcriptional induction of ERBB3

Sun, C., Hobor, S., Bertotti, A., Zecchin, D., Huang, S., Galimi, F., Cottino, F., Prahallad, A., Grernrum, W., Tzani, A., Schlicker, A., Wessels, L. F. A., Smit, E. F., Thunnissen, E., Halonen, P., Lieftink, C., Beijersbergen, R. L., DiNicolantonio, F., Bardelli, A., Trusolino, L. & 1 others, Bernards, R., Oct 4 2014, In : Cell Reports. 7, 1, p. 86-93 8 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
Colonic Neoplasms
Lung Neoplasms
Phosphorylation
Receptor Protein-Tyrosine Kinases
365 Citations (Scopus)

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer

Bardelli, A., Corso, S., Bertotti, A., Hobor, S., Valtorta, E., Siravegna, G., Sartore-Bianchi, A., Scala, E., Cassingena, A., Zecchin, D., Apicella, M., Migliardi, G., Galimi, F., Lauricella, C., Zanon, C., Perera, T., Veronese, S., Corti, G., Amatu, A., Gambacorta, M. & 8 others, Diaz, L. A., Sausen, M., Velculescu, V. E., Comoglio, P., Trusolino, L., Di Nicolantonio, F., Giordano, S. & Siena, S., 2013, In : Cancer Discovery. 3, 6, p. 658-673 16 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Colorectal Neoplasms
Proto-Oncogenes
Therapeutics
Mutation